EMERGING PATTERNS OF HEART-DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

被引：72
|
作者：
ANDERSON, DW
VIRMANI, R
机构：
[1] ARMED FORCES INST PATHOL,DEPT CARDIOVASC PATHOL,WASHINGTON,DC 20306
[2] US FDA,CTR DRUGS EVALUAT & RES,DIV ANTIVIRAL DRUG PROD,ROCKVILLE,MD 20857
来源：
HUMAN PATHOLOGY | 1990年 / 21卷 / 03期
关键词：
cardiomyopathy; heart disease patterns; HIV disease; pericardial effusion;
D O I：
10.1016/0046-8177(90)90224-S
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
[No abstract available]
引用
收藏
页码：253 / 259
页数：7
相关论文
共 30 条
  • [11] PHARMACOEPIDEMIOLOGY OF ADVERSE DRUG-REACTIONS IN HOSPITALIZED-PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE
    HARB, GE
    ALLDREDGE, BK
    COLEMAN, R
    JACOBSON, MA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (08): : 919 - 926
  • [12] Risk of Heart Failure With Human Immunodeficiency Virus in the Absence of Prior Diagnosis of Coronary Heart Disease
    Butt, Adeel A.
    Chang, Chung-Chou
    Kuller, Lewis
    Goetz, Matthew Bidwell
    Leaf, David
    Rimland, David
    Gibert, Cynthia L.
    Oursler, Krisann K.
    Rodriguez-Barradas, Maria C.
    Lim, Joseph
    Kazis, Lewis E.
    Gottlieb, Stephen
    Justice, Amy C.
    Freiberg, Matthew S.
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (08) : 737 - 743
  • [13] Diastolic dysfunction in human immunodeficiency virus infection
    Hernández, FH
    Rubia, RG
    Subías, PE
    Martín, MTV
    Romero, FL
    García, RR
    Ortega, FP
    Pérez-Herrero, JRC
    de la Calzada, CS
    REVISTA ESPANOLA DE CARDIOLOGIA, 2001, 54 (10): : 1183 - 1189
  • [14] Heart Failure in Patients With Human Immunodeficiency Virus Infection Epidemiology, Pathophysiology, Treatment, and Future Research
    Remick, Joshua
    Georgiopoulou, Vasiliki
    Marti, Catherine
    Ofotokun, Igho
    Kalogeropoulos, Andreas
    Lewis, William
    Butler, Javed
    CIRCULATION, 2014, 129 (17) : 1781 - 1789
  • [15] Myocardial disease in human immunodeficiency virus (HIV) infection: a reviewHIV und Erkrankungen des Myokards
    Mahmoud Umar Sani
    Wiener klinische Wochenschrift, 2008, 120 : 77 - 87
  • [16] Reversible cardiomyopathy subsequent to perinatal infection with the human immunodeficiency virus
    Diógenes, MSB
    Carvalho, ACC
    Succi, RCDM
    CARDIOLOGY IN THE YOUNG, 2003, 13 (04) : 373 - 376
  • [17] Left Ventricular Systolic Function in Nigerian Children with Human Immunodeficiency Virus Infection
    Ige, Olukemi Omowumi
    Oguche, Stephen
    Bode-Thomas, Fidelia
    CONGENITAL HEART DISEASE, 2012, 7 (05) : 417 - 422
  • [18] MYOCARDIAL RISK-FACTORS OTHER THAN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION MAY CONTRIBUTE TO HISTOLOGIC CARDIOMYOPATHIC CHANGES IN ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME
    SEGAL, BH
    FACTOR, SM
    MODERN PATHOLOGY, 1993, 6 (05) : 560 - 564
  • [19] Off-label drug use in human immunodeficiency virus disease
    Brosgart, CL
    Mitchell, T
    Charlebois, E
    Coleman, R
    Mehalko, S
    Young, J
    Abrams, DI
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 12 (01): : 56 - 62
  • [20] Infection of human fetal cardiac myocytes by a human immunodeficiency virus-1-derived vector
    Rebolledo, MA
    Krogstad, P
    Chen, FH
    Shannon, KM
    Klitzner, TS
    CIRCULATION RESEARCH, 1998, 83 (07) : 738 - 742
123